Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma (NCT07282587)

🧪 Interventions in This Study

• ONC206 (DRUG)
• ONC206: Dose 1 (DRUG)
• ONC206: Dose 2 (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (9 Sites)

• UCLA — Los Angeles, California
• Stanford — Palo Alto, California
• U of Colorado — Aurora, Colorado
• U of Michigan — Ann Arbor, Michigan
• Mayo-Rochester — Rochester, Minnesota
• Washington University — St Louis, Missouri
• Columbia University Medical Center — New York, New York
• PENN — Philadelphia, Pennsylvania
• UTAH — Salt Lake City, Utah

📞 Contact the Study Coordinator

Phone: (215) 832-3750

Email: ClinicalTrialDisclosure@jazzpharma.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Advanced Pheochromocytoma and Paraganglioma clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.